Xhosa
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Zhong Dingsheng

Isibhedlele Jikelele seYunivesithi yezoNyango yaseTianjin
UMlawuli weSebe le-Medical Oncology, uMlawuli weZiko lezeMpilo le-Medical Oncology, uGqirha oyiNtloko, uNjingalwazi, uMphathi woGqirha. Ufunde waza wasebenza kwiWinship Cancer Institute of Emory University School of Medicine ukususela ngo-2000 ukuya ku-2008. Unamava amaninzi eklinikhi kunyango oluqhelekileyo lwee-tumor, ngakumbi kwicandelo lokuxilongwa kwangoko komhlaza wemiphunga, i-chemotherapy, unyango olujoliswe kuyo kunye nonyango oluchasene ne-angiogenic. Ngokuphathelele uphando lwesayensi kunye nempumelelo yezemfundo, ufumene izibonelelo ezine kwiNational Natural Science Foundation yaseTshayina kwiiprojekthi eziphezulu, izibonelelo ezimbini kwiNatural Science Foundation yaseTianjin, kwaye wathatha inxaxheba kwiiprojekthi ezintandathu eziphambili zesizwe kunye nezophando zaseTianjin njengomthathi-nxaxheba omkhulu, kunye neeprojekthi ezininzi ezivela kwiTianjin Municipal Health Bureau kunye neTianjin Medical University. Okwangoku, upapashe amaphepha emfundo angaphezu kwama-90, apho angaphezu kwama-40 akwisiNgesi, kunye ne-IF factor edibeneyo engaphezulu kwe-100. Kwiminyaka eli-10 edlulileyo, ebelawula abafundi abangaphezu kwama-30 besidanga se-master kunye nabafundi abangama-20 bobugqirha. Usebenza njengelungu lebhodi elawulayo yokuhlela kwiChinese Journal of Lung Cancer, ilungu lebhodi elawulayo kwiijenali ezahlukeneyo ezifana neTianjin Medicine, iInternational Journal of Oncology kunye neInternational Respiratory Journal. Ulilungu leChinese Medical Association Oncology Branch, ilungu leLung Cancer Group of Respiratory Branch of Chinese Medical Association, ilungu leOncology Group of Chinese Geriatrics Society, usekela-sihlalo wePalliative Medicine Committee of Beijing Oncology Society, usekela-sihlalo weOncology Specialty Committee of Tianjin Medical Experts Committee, usekela-sihlalo wePrecision Medicine Specialty Committee of Tianjin Physicians Association, kunye nenkokeli yeLung Cancer Specialty Group of Tianjin Targeted Specialty Committee of China Anti-cancer Association. Ukwayintloko yeLung Cancer Specialized Group of Tianjin Targeted Specialized Committee of Chinese Anti-Cancer Association.

Zhong Dingsheng